A Double Negative Effect on Lymphoma
Cancer cells are extremely versatile and adaptable. They find ways to wiggle out of any attempts to restrain them. Researchers are working with the very mechanism that cancer uses to avoid death to develop a potentially powerful therapy for lymphoma.
Chemo Gets the Job Done Alone
A long-term risk analysis of Hodgkin lymphoma patients shows that the traditional practice of using radiation together with chemotherapy may be too much, causing more problems without extending life expectancy.
Safer Treatment for Skin Lymphoma
Part of the process of developing and testing drugs involves seeing if treatments work in similar conditions, and science is full of surprises.
Cephalon, Inc. Issues Voluntary Nationwide Recall of Treanda
Cephalon , Inc. is voluntarily recalling Treanda ® ( bendamustine HCL ) for Injection 25mg / 8mL ; lot TB30111 , expiration date 12/2012. This product lot is being recalled due to the presence of particulate matter found in a single vial, which has been identified as glass fragments.
FDA Approves Subcutaneous Administration of Takeda Drug Velcade
The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application ( sNDA ) for Velcade ( bortezomib ).
FDA Drug Safety Communication: Adcetris (brentuximab vedotin)
The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy ( PML ), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris ( brentuximab vedotin ).
Two Sisters Help Understand One Disease
It's well known that cancer can be passed between a donor and recipient during a transplant operation. One such exchange has actually advanced the scientific understanding of lymphoma.
New Lymphoma Bull's-Eye
It's the most aggressive blood cancer. Unfortunately, Diffuse Large B-Cell Lymphoma ( DLBCL ) is also the most common form of lymphoma in adults. But there is some good news - researchers may have a new target for treating this disease.
Horizon Brightening for Lymphoma
Just because something works in mice, doesn't mean it will work in humans. That being said, a new mouse study holds out hope for a new therapy for lymphoma. Researchers have identified two molecules that are better killers of lymphoma than existing therapies. These findings, if they hold true for humans, could lead to new cancer therapies. Ask your doctor about the very latest science relating to lymphoma therapies. First author Hye-Ra Lee, Ph.D., a research fellow in the Department of Molecular Microbiology & Immunology at the Keck School of Medicine of the University of So...
Diet and Weight - Are There Lymphoma Risks?
What you eat today could impact your health 10 years from now. That's what's becoming increasingly clear in medical research, and a new study confirms this.